IMUGENE LTD.IMUGENE LTD.IMUGENE LTD.

IMUGENE LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪259.09 M‬EUR
−0.0081EUR
‪−23.15 M‬EUR
‪6.18 B‬
Beta (1Y)
1.74

About IMUGENE LIMITED

CEO
Leslie Chong
Headquarters
Carlton
Founded
1986
ISIN
AU000000IMU9
FIGI
BBG000QBRR16
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IMUGENE LTD. stocks are traded under the ticker ILA.
We've gathered analysts' opinions on IMUGENE LTD. future price: according to them, ILA price has a max estimate of 0.26 EUR and a min estimate of 0.09 EUR. Watch ILA chart and read a more detailed IMUGENE LTD. stock forecast: see what analysts think of IMUGENE LTD. and suggest that you do with its stocks.
ILA reached its all-time high on Jun 28, 2024 with the price of 0.0338 EUR, and its all-time low was 0.0319 EUR and was reached on Jun 27, 2024. View more price dynamics on ILA chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track IMUGENE LTD. financials in yearly and quarterly reports right on TradingView.
IMUGENE LTD. is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
IMUGENE LTD. revenue for the last half-year amounts to ‪2.50 M‬ EUR, despite the estimated figure of 0 EUR. In the next half-year revenue is expected to reach ‪2.46 M‬ EUR.
ILA net income for the last half-year is ‪−42.38 M‬ EUR, while the previous report showed ‪−12.53 M‬ EUR of net income which accounts for −238.23% change. Track more IMUGENE LTD. financial stats to get the full picture.
No, ILA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ILA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMUGENE LTD. stock right from TradingView charts — choose your broker and connect to your account.